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Abstract
Background: The aim of this study was to determine whether prior antimicrobial therapy is an important risk factor for
extended antimicrobial therapy among critically ill children. To evaluate other predisposing factors influencing the usage of
antibiotics in a pediatric intensive care unit (PICU) setting. To examine the relationship between the extent of antimicrobial
treatment and the incidence of nosocomial infections and outcome.
Methods: This prospective observational cohort study was conducted at a university-affiliated teaching hospital (760 beds) in
Athens. Clinical data were collected upon admission and on each consecutive PICU day. The primary reason for PICU admission
was recorded using a modified classification for mutually exclusive disease categories. All administered antibiotics to the PICU
patients were recorded during a six-month period. Microbiological and pharmacological data were also collected over this
period. The cumulative per patient and the maximum per day numbers of administered antibiotics, as well as the duration of
administration were related to the following factors: Number of antibiotics which the patients were already receiving the day
before admission, age groups, place of origin, the severity of illness, the primary disease and its complications during the course
of hospitalization, the development of nosocomial infections with positive cultures, the presence of chronic disease or
immunodeficiency, various interventional techniques (mechanical ventilation, central catheters), and PICU outcome.
Results: During a six-month period 174 patients were admitted to the PICU and received antibiotics for a total of 950 days
(62.3% of the length of stay days). While in PICU, 34 patients did not receive antimicrobial treatment (19.5%), 69 received one
antibiotic (39.7%), 42 two (24.1%), 17 three (9.8%), and 12 more than three (6.9%). The number of antibiotics prescribed in
PICU or at discharge did not differ from that at admission. Indications for receiving antibiotics the day before admission and
throughout during hospitalization into PICU were significantly correlated. Although the cumulative number of administered
antibiotics did not correlate with mortality (9.8%), it was significantly related to the severity scoring systems PRISM (p < .001),
TISS (p < .002) and was significantly related to the number of isolated microorganisms (p < .0001). Multiple regression analysis
demonstrated that independent determinants of the cumulative number of antibiotics were: prior administration of antibiotics,
presence of a bloodstream infection, positive bronchial cultures, immunodeficiency, and severity of illness.
Conclusion: Prior antimicrobial therapy should be recognized as an important risk factor for extended antimicrobial therapy
among critically ill children. Severity of illness, immunodeficiency, and prolonged length of stay are additional risk factors.
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Background
Judicious use of antibiotics in ambulatory practice has
become increasingly important as antibiotic resistance in
community bacterial pathogens continues to accelerate. It
has been estimated that approximately 60% of all antibi-
otics prescribed in outpatients are for documented or sus-
pected respiratory infection and that the highest rates of
antibiotic use are in children [1].
The high risks associated with untreated infection in hos-
pital patients lower the threshold for prescription of anti-
biotic treatment. In a twenty-year period, and despite the
increasing breadth of activity of individual compounds,
the percentage of patients receiving combinations of anti-
biotics, as opposed to single antibiotic administration,
increased from 23% to 44% [2]. Extensive use of broad-
spectrum antibiotics and crowding of severely ill patients
in intensive care units has led worldwide to important
increases in nosocomial-related infections.
Patients admitted to adult or pediatric intensive care units
(PICU) are at greatest risk of acquiring nosocomial infec-
tions, partly because of their serious underlying diseases,
but also because of their exposure to life-saving invasive
procedures, prolonged use of in-situ invasive devices,
therapy with multiple antimicrobial agents, and extended
hospital stays [3-5]. Even patients and their surroundings
are known reservoirs for nosocomial pathogens [6,7]. In
most studies, however, antimicrobial use has been
assumed to be the major factor responsible for changes in
resistance [8].
In order to minimize unwarranted prescription of broad-
spectrum antibiotics and to reduce the frequency of addi-
tional morbidity and mortality because of nosocomial
infections, antibiotic prescription in our PICU was
imposed by definite clinical indications [9], guided by
microbial studies. Not unusually, however, admitted
high-risk patients have already been covered with broad-
spectrum antibiotics for prophylaxis or for treating docu-
mented or suspected infection in their own departments
[10].
We hypothesized that prior antimicrobial therapy might
be an important risk factor for extended antimicrobial
therapy in PICU and that other predisposing factors such
as a significant proportion of immuno-compromised or
cancer patients, patients with prolonged length of stay, or
increased degree of interventions might further restrict
clinical efforts aimed at reducing antimicrobial treatment
in critically ill patients. Subsequently, the increased usage
of antibiotics in this group of patients might lead to devel-
opment of nosocomial infections and increased morbid-
ity and mortality. The objectives of this study, therefore,
were a) to determine whether prior antimicrobial therapy
is an important risk factor for extended antimicrobial
therapy among critically ill children; b) to evaluate other
predisposing factors influencing the usage of antibiotics
in a PICU setting; c) to examine the relationship between
the extent of antimicrobial treatment and the incidence of
nosocomial infections and outcome.
Methods
Patients
This prospective observational cohort study was con-
ducted at a university-affiliated teaching hospital: Aghia
Sophia Children's Hospital (760 beds) in Athens. Subjects
included all patients admitted to the PICU (10 beds)
between September 2001 and March 2002. As the study
did not affect patient care, the institutional review board
waived the need for informed parental consent. Reasons
for admission included postoperative care after pediatric
surgery, severe trauma, and medical conditions requiring
critical care. Antibiotic prescription in PICU was imposed
by definite clinical indications, guided by microbial stud-
ies. Before microbiology was available, empiric therapy
was based on: (i) proper identification of bacterial risks in
each infection site; (ii) surveillance of frequent nosoco-
mial organisms and susceptibility patterns in the PICU;
(iii) identification of environmental risk factors and the
patient's underlying condition. In documented infection,
initial selection of antibiotics was based on patient char-
acteristics, local drug resistance patterns, the patient's
prior exposure to specific classes of antibiotics, pharma-
cokinetics / pharmacodynamic parameters of chosen anti-
biotics and concentrations at the infection site, in order to
prevent selection of resistant mutants and to provide the
most efficient antibiotic therapy. Our restriction program
also required clinical justification for the specific antibi-
otic order before the drug is dispensed by the pharmacy.
These regimens were administered before definitive proof
of infections and until the results of microbial
investigation were available (de-escalation antimicrobial
chemotherapy) [11]. As culture results from respiratory
specimens became available, they were used to narrow the
range of pathogens targeted by the original regimen. In
particular de-escalation antimicrobial chemotherapy was
tailored to our critically ill patients according to their clin-
ical status, severity of illness and suspicion of sepsis or
nosocomial pneumonia. Cycling antibiotic therapy was
only periodically instituted, in order to avoid the develop-
ment of bacterial resistance.
In order to avoid both, inadequate antimicrobial treat-
ment and inappropriate antibiotic over-prescription,
therefore, our approach to addressing the problem of anti-
biotic use in our PICU was to: develop periodic guidelines
for optimal use of antibiotics, including scheduled
changes of antibiotic classes or single antibiotics within
classes (aminoglycosides, ureidopenicillins,Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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cephalosporins), monitor and report broad-spectrum
antibiotic use, improve antimicrobial prescribing by edu-
cational and administrative means, optimize choice and
duration of empiric therapies by allowing for the selection
of the most effective antimicrobial agents, and, when fea-
sible, optimize or modify prophylaxis after operative pro-
cedures. These guidelines could not affect previous
antibiotic prescription in our patients' original depart-
ments, which had their own policies and had often been
the main sources of our patients. Not unusually, there-
fore, admitted patients had already been covered with
antibiotics for prophylaxis or for treating documented or
suspected infection by their own attending surgeons,
oncologists, or other specialists. Accordingly, all consecu-
tively admitted patients to our PICU during a six-month
period entered the study.
Data collections and definitions
Clinical data were collected upon admission and on each
consecutive PICU day. The primary reason for PICU
admission was recorded using a modified classification
for mutually exclusive disease categories [12]. Final diag-
nostic information was coded by combining appropriate
for the age groups and the intensive care settings modifi-
cations of the International Classification of Diseases and
the Guidelines for Developing Admission and Discharge
Policies for the Pediatric Intensive Care Unit [13], and
admission criteria proposed by the Guidelines for Inten-
sive Care Unit Admission, Discharge, and Triage, follow-
ing a Prioritization Model [14]. Chronic co morbidity was
classified as 1) none, independent of care of others for
activities of daily life, 2) chronic disease or handicapped
partially or fully dependent on care of others, and 3) can-
cer patient. Strict guidelines and protocols for central
venous catheter insertion, care, and maintenance where
implemented. All blood cultures for establishing the pres-
ence of a bloodstream infection were required to be
obtained from percutaneously drawn sites using sterile
technique and not drawn from indwelling vascular cathe-
ters. Patients were evaluated for the development of
bloodstream infections only during their stay in the PICU.
Patients in whom there was a suspicion of clinical or radi-
ologic ventilator-associated pneumonia (VAP) underwent
bronchoscopy, and pneumonia was confirmed by the
presence of bronchoalveolar lavage fluid culture.
Microbiological and pharmacological data
All administered antibiotics to the PICU patients were
recorded during a six-month period. Microbiological and
pharmacological data were also collected over this period.
Bacteremia was defined as the identification of a high-
grade pathogen (e.g., Pseudomonas aeruginosa, Staphylococ-
cus aureus) in a blood culture specimen or the identifica-
tion of a common skin contaminant or skin flora (e.g.,
coagulase-negative staphylococci) in at least two separate
blood culture specimens from the same patient drawn
from different sites. Bacteraemias identified from blood
cultures collected within 48 hours of admission were
deemed to be community-acquired. Nosocomial blood-
stream infections were required to be established after 48
h of hospitalization. Similar temporal cutoffs for separat-
ing community-acquired infections from hospital-
acquired infections have been proposed by other investi-
gators [15]. Patients residing at a nursing home, skilled-
care facility, or rehabilitation center who had a blood-
stream infection requiring hospital admission were classi-
fied as having community-acquired infections.
Nosocomial bloodstream infections, as well as other
nosocomial infections (urinary tract, wound infection),
were defined according to criteria established by the Cent-
ers for Disease Control and Prevention [16]. The diagnos-
tic criteria for VAP were modified from those established
by the American College of Chest Physicians, as previ-
ously described [17]. Antimicrobial resistance was deter-
mined for all clinical isolates assumed to be significant for
the clinical condition of the patient. Duplicate isolates
were excluded from the study and were defined as isolates
of the same organism obtained from the same patient
within a 7-day period.
The cumulative per patient and the maximum per day
numbers of administered antibiotics, as well as the dura-
tion of administration were related to the following fac-
tors: Number of antibiotics which the patients were
already receiving the day before admission, age groups,
place of origin, the severity of illness, the primary disease
and its complications during the course of hospitaliza-
tion, the development of nosocomial infections with pos-
itive cultures, the presence of chronic disease or
immunodeficiency, various interventional techniques
(mechanical ventilation, central catheters), and PICU out-
come. The severity of illness was assessed by the Pediatric
Risk of Mortality (PRISM) Score [18], the Therapeutic
Intervention Scoring System (TISS) modified for children
[19], and indices of organ failure. Multiple organ system
failure (MOSF) was defined using the criteria by Wilkin-
son et al [20].
Statistical analysis
Normally distributed data are expressed as mean ± SEM,
while non-normally distributed data are given as median
and range. Statistical analysis was performed with a two-
tailed t-test for normally distributed paired data after Lev-
ene's correction for equality of variances or by Mann-
Whitney U – Wilcoxon rank sum W test for non-normally
distributed data. Probability values of <.05 with two-
tailed tests were considered significant. When a linear
regression was calculated Pearson's correlation coefficient
was employed. Fisher's exact test was used for the category
data. Clinical characteristics, that showed significantAnnals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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differences in univariate analysis were subsequently
examined in stepwise multiple regression analysis with
the cumulative per patient number of administered anti-
biotics, the maximum per day number, and the duration
of administration as dependent variables, using p = .05 for
entry and p = .01 for removal. In this analysis, the contri-
bution of each determinant, or resource utilization, was
assessed in connection with all others. All analyses were
done using the Statistical Package for the Social Sciences
(SPSS) for Windows (release 10, SPSS, Chicago, IL) soft-
ware package.
Results
Patients' characteristics
During the 6-month period, 174 patients, mean age 5 ± .4
(.6–19) years, 59.2% boys – 40.8% girls, were admitted to
the PICU. Clinical data and data regarding antibiotic
usage in PICU are shown in Table 1. Free medical history
had 40.8% of the patients, cancer 23.6%, and chronic dis-
ease 35.6%. Among the patients, 91% admitted to the
PICU for the first time (158/174), 13 had 2 admissions
(7.5%) and 3 more than 2 admissions. The place of origin
was 12.6% directly from the emergency department,
43.7% from the wards, 11.5% were transferred from other
hospitals, 24.1% from the operative room (elective major
surgeries), 3% from emergent operations, 3.4% were long
distance air-transported, and 1.7% were chronically ill
patients who were directly transferred from their homes.
On the total, 54.6% were supported with mechanical ven-
tilation (MV). The mortality rate was 9.8%, and differed
significantly between those who were supported with MV
(17.9%), compared to those who were not supported
(0%, p < .0001). Among the patients, 6.3% had neutrope-
nia upon admission (mortality 27.3%), while 4.6% had
immunodeficiency (mortality 40%).
Classification
Among disease groups, oncology patients were more fre-
quently hospitalized (41/23.6%, mortality 9.8%),
patients with chronic disease, such as metabolic, (28/
16.1%, mortality 17.9%), primary respiratory deficiency
(25/14.4%, no mortality) and sepsis, not including
patients from the previous groups (17/9.8%, mortality
11.8%). Classifying patients according to primary organic
system according to the International Classification of
Diseases and the Guidelines for Developing Admission
and Discharge Policies for the Pediatric Intensive Care
Unit, more often admitted in our PICU patients with car-
diovascular instability, especially patients with septic
shock (32.8%), postoperative patients after severe or
emergent operations (24.7%), neurological problems,
such as status epilepticus or coma (19.5%) and acute res-
piratory problems (10.3%). Regarding the admission to
the PICU according to the Prioritization Model, most
patients were admitted with acute manifestations of
severe diseases with priority 1–2. The frequency of various
interventions related to possible aggravating factors in
using antibiotics in critically ill children is presented in
Table 2.
Antimicrobial treatment
Frequency of coverage
The study population received antibiotics for a total of
950 days (5.6 ± .7 days, 0–56), which represented 62.3%
of the cumulative 1526 length of stay days, compared
with 1067 days on MV (6.1 ± 1.4 days, 0–180), which,
however, represented 70% of the cumulative length of
stay. While in PICU, 34 patients did not receive antimicro-
bial treatment (19.5%), 69 received one antibiotic
(39.7%), 42 two (24.1%), 17 three (9.8%), and 12 more
than three (6.9%), including agents against fungi and
viruses.
Table 1: Clinical variables and antibiotic coverage of children in PICU during a six-month period (n = 174)
Variables Mean ± SEM Median Minimum Maximum
Age (years) 5 ± 0.4 3.5 0.6 - 19
Length of Stay (days) 8.8 ± 1.6 2 1 - 180
Duration of Mechanical Ventilation (days) 6.1 ± 1.4 1 0 - 180
TISS 24.6 ± 1.0 21 9 - 61
PRISM 10.8 ± 0.7 8 0 - 60
Possibility of death by PRISM (%) 11.9 ± 1.7 3 0 - 100
Number of antibiotics upon admission 1.1 ± 0.08 1 0 - 7
Maximum daily number of antibiotics given in PICU 1.2 ± 0.07 1 0 - 4
Cumulative number of antibiotics in PICU throughout during the hospitalization 1.4 ± 0.09 1 0 - 8
Cumulative number of antibiotics, including antiviral and antifungal, in PICU 1.56 ± 0.1 1 0 - 10
Number of antibiotics at discharge 1.14 ± 0.07 1 0 - 4
Duration of antibiotics in PICU (days) 6.1 ± 0.8 2 0 - 56
SEM = Standard error of mean; PRISM = Pediatric Risk of Mortality; TISS = Therapeutic Intervention Scoring SystemAnnals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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Antibiotics upon admission, in PICU and at discharge
Not only the maximum per patient number of adminis-
tered antibiotics (r2 = .7, p < .01), but also the cumulative
summary of antibiotics (r2 = .62, p < .01) and the number
of antibiotics which the patients were receiving at
discharge (r2 = .4, p < .01), were significantly correlated
with the number of antibiotics which the patients were
already receiving on the admission day. Antibiotics in
PICU covered 79.9% of patients, compared to the 67.2%
of the covered patients during admission day (p < .0001).
A significant proportion of those antibiotics started only
after admission to PICU represented patients with chronic
diseases and long length of stay (4 patients not receiving
antibiotics in PICU vs. 10 upon admission, p < .01) and
patients with head injury who had always been admitted
directly to the PICU without receiving antibiotics (15
patients) but received afterwards for intervening infection
(5 patients without receiving antibiotics in PICU). Smaller
differences were recorded among oncology patients (3
patients without receiving antibiotics in PICU vs. 5 upon
admission) or patients with sepsis (no patients without
receiving antibiotics in PICU vs. 1 upon admission). At
discharge, 24.7% of patients did not receive any
antibiotic, 43.1% one, 27% two, 3.4% three, 1.7% four.
The numbers of antibiotics during hospitalisation in
PICU or at discharge did not differ from those of received
antibiotics the day before admission (Figure 1).
Regarding the maximum daily number of antibiotics per
patient, not including agents against fungi and viruses,
21% of patients in PICU did not receive any antibiotic
compared to 32.8% of the same patients who were not
receiving antibiotics the day before admission. While in
PICU, 46% of patients received only one antibiotic com-
pared to 32.8% receiving one antibiotic before admission,
two antibiotics 25.9% compared to 24.1%, three 5.7%
versus 6.9%, and four 1.7% versus 1.8%. Oncology and
Table 2: Frequency of various interventions related to possible aggravating factors predisposing to increasing administration of 
antibiotics in PICU (n = 174)
INTERVENTION KINDS OF INTERVENTION FREQUENCY
CATHETERS Peripheral veins 17,8%
Peripheral veins + arteries 22,4%
Central catheter (one) 34,5%
Central catheters 2+ 25,4%
NUTRITION Total Parenteral Nutrition 6,9%
Enteral (nasogastric, transpyloric) 84,5%
HEMODYNAMIC PiCCO 12,1%
Inotropes 22,4%
BRAIN MONITORING ICP catheters ± SjVO2 5,7%
NEUROSURGICAL External CSF drainage 8,6%
KIDNEYS' ARTIFICIAL SUPPORT Hemofiltration continuous 3,4%
Peritoneal dialysis 1,7%
RESPIRATORY SUPPORT Mechanical Ventilation 54.6%
High Frequency Ventilation 2,2%
Tracheotomy 4,6%
Chest drains 7,9%
PiCCO = Pulse contour cardiac output
Antibiotics before, at, and after PICU Figure 1
Antibiotics before, at, and after PICU. Box plots of the 
medians of antibiotics, which the patients were receiving the 
day before admission (one day recording), during hospitalisa-
tion in PICU (mean 9 days recording, range 1–180 days), and 
at discharge (one day recording).Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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neurosurgery patients admitted to the PICU were already
receiving antibiotics at percentages as high as 90.2% and
82%, respectively. Neurosurgery patients had already
being receiving two antibiotics in 44.8% (usually ceftazi-
dime and vancomycin), whereas leukemia patients were
already receiving 6 or 7 antibiotics, including carbapen-
ems, aminoglycosides, and agents against fungi and
viruses, in 40%. At admission, patients with metabolic or
mitochondrial diseases were already receiving one or two
antibiotics in 50%, whereas general surgery patients were
receiving one antibiotic in 44% and two or more in
33.3%. In contrast, 100% of burns or head injury patients,
86% of patients with congenital heart disease, 67% of
patients with non-febrile seizures, and 58.3% of patients
with bronchiolitis had not received any antibiotic before
admission to the PICU. At the same time 55.5% of
patients with sepsis were receiving only one antibiotic
while 11% had not yet received any antibiotic (most of
them admitted directly through the ED). Among oncology
and neurosurgery patients the mean number of antibiot-
ics per patient in PICU was reduced (1.6 and .4, respec-
tively), compared to the mean number of antibiotics
received upon admission (1.8 and .5, respectively, p <
.0001), while it remained unchanged in the accident
group (Figure 2). Paired differences between the numbers
of antibiotics given before admission or at discharge and
Antibiotics in various diagnostic groups related to PICU admission Figure 2
Antibiotics in various diagnostic groups related to PICU admission. Comparison of the mean number of antibiotics in 
various disease groups in PICU with the mean number of antibiotics received upon admission in the same patients.Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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the maximum (but not the cumulative: p < .001) number
of antibiotics in PICU were not significant.
Prior use of antibiotics
Patients already receiving antibiotics were at higher risk of
been infected with nosocomial microorganisms isolated
in blood (15.4% vs. 8%), bronchial (21.4% vs. 15.8%),
and cumulative cultures from different sites (31% vs.
21%, p < .002). These patients were also at higher risk of
developing various nosocomial infections (Figure 3) and
septic shock (9% vs. 2%, p < .002), but not nosocomial
pneumonia (10.2%), despite the fact that more patients
who had received antibiotics were supported with
mechanical ventilation (57%) compared to patients who
had not received antibiotics previously (49%). Regarding
antibiotics, patients who were already receiving antibiot-
ics were at significantly higher risk of receiving higher per-
centages of antibiotics in PICU in (98% vs. 44%, p < .02)
and of receiving significantly higher daily and cumulative
number of antibiotics (p < .0001), especially aminoglyco-
sides (25% vs. 9%, p = .003), agents against fungi (9.4%
vs. 3.5%, p = .05), ureidopenicillins with β-lactamase
inhibitors (29% vs. 8.8%, p < .03), and ceftazidime
(14.5% vs. 3.5%, p < .03), but not carbapenems (p = .3),
Antibiotics usage, changes, isolates and nosocomial infections Figure 3
Antibiotics usage, changes, isolates and nosocomial infections. Differences in mean numbers of antibiotics usage, 
changes, isolates and nosocomial infections in PICU (after admission) between patients who were receiving or not receiving 
antibiotics the day before admission to the PICU.Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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which most of these patients had already been started on
before admission (Figure 3). Finally, patients with prior
administration of antibiotics needed significantly more
changes in antibiotic regimens during their hospitaliza-
tion in PICU (.46 ± .09 vs. .12 ± .06, p < 003). Of those
receiving antibiotics before admission, 70 were post-sur-
gical patients and/or patients with cancer (83% receiving
antibiotics), whereas of the remaining 104, only 34%
were receiving antibiotics for suspected infection or infec-
tion of community (p < .0001). While in PICU, these per-
centages did not change significantly and their differences
remained unchanged (92% for the post-surgical and can-
cer patients receiving antibiotics vs. 48% for the rest
patients with acute or chronic diseases, p < .0001).
Indications for prescribing antibiotics
Indications for prescribing antibiotics the days before
admission and during hospitalization in the PICU were
significantly correlated and recorded as follows: No indi-
cation – no antibiotics 32.8% before vs. 20.1% after
admission, antibiotics for prophylaxis 22.4% vs. 24.7%,
suspected infection not proved 10.9% vs. 10.9%,
immuno-compromised cancer patients with fever or other
clinical signs of infection 6.3% vs. 5.2%, infection of com-
munity (sepsis, pneumonia, meningitis, etc) 27.6% vs.
Resource utilisation in various indications for antibiotics usage Figure 4
Resource utilisation in various indications for antibiotics usage. Relation of the length of stay and mechanical ventila-
tion duration to various indications for prescribing antibiotics in PICU.Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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32.8%, p < .0001, and nosocomial infection while in
PICU 6.3%. Although some of the last group patients who
suffered of chronic metabolic or mitochondrial diseases
or brain hemorrhages did not initially receive antibiotics,
they subsequently developed VAP, probably because of
the prolonged length of stay and mechanical ventilation
duration, and finally received various combinations of
antibiotics (Figure 4). Patients who had received antibiot-
ics only for prophylaxis before admission, finally received
more antibiotics in PICU than patients who had not
received antibiotics previously (1.7 ± .2 vs. .6 ± .1, p <
.0001).
Length of stay and antibiotics
Patients who stayed more than one week (40 patients) in
the PICU received significantly higher number of antibiot-
ics than the 134 patients hospitalised less than 8 days (2.5
± .28 vs. 1.1 ± .02, p < .0001). Similarly, the antibiotics
prescribed differed significantly between the 65 who were
hospitalised more than 3 days and the109 patients who
were hospitalised less than 3 days (2.1 ± .2 vs. 1.0 ± .8, p
< .0001).
Microbial studies
Positive cultures during hospitalization were isolated in
60 bronchial secretions (26 during the 1st week, 21 the 2nd
week, 13 the 3rd week) of 34 patients (19.5%), 28 blood
cultures (18 during the 1st week, 10 beyond the 2nd week)
in 23 patients (13.2%), 16 urine cultures (9%), 16 pleu-
ritic or other body fluids and in 16 CSF (9%, including
admission CSF of patients with meningitis), all of which
were significantly related to the cumulative longitudinal
number of received antibiotics (p < .0001) and were also
significantly more frequently isolated in the group receiv-
ing antibiotics (Figure 5). Most of these isolates were sen-
sitive to either ureidopenicillins and aminoglycosides
(gram negative) or teicoplanin and vancomycin (gram
positive strains). Cumulative sum of received antibiotics
during hospitalization in PICU was significantly related to
the number of isolated microorganisms (26% of patients,
p < .0001). This significant correlation was retained when
antiviral and antifungal agents were also taken into
account (r2 = .6, p < .0001), while borderline was the cor-
relation of administered antibiotics at admission or dis-
charge to the positive culture results (p = .05).
Correlation to clinical factors
A higher percentage of patients admitted from the OR
(85.7%) or the wards (84.2%) had still been receiving
antibiotics compared to those admitted from the ED
(72.7%), home (66.7%) or other hospitals (65%),
although this difference did not reach statistical signifi-
cance. Similarly, significant was the burden of 51 patients
with chronic disease (90.2% received antibiotics) or 37
patients with tumors (82.3%) in relation to 39 medical
and 12 surgical patients with free previous medical history
(73.2%, p < .03). Differences were also recorded among
disease groups regarding the number of administered
antibiotics (septic shock 100%, tumors 92.7%, surgical
88.2 compared to only 40% for neurological, 50% acci-
dents and 60% respiratory diseases, p < .0001), predomi-
nant organic systems affected (respiratory 75.4%, septic
shock 94.4%, p < .02), priority admission model (77.2%
priority I vs. 92.6% priority III, p < .05). Finally,
significantly larger number of antibiotics has been given
to patients supported with mechanical ventilation
(89.5%) compared to that administered to patients who
were not mechanically supported (68.4%, p = .003) and
had also received a smaller mean number of daily antibi-
otics. In the whole study population (including patients
with cancer or major surgery), VAP had developed 11
patients (10.4%), nosocomial sepsis 23 patients (13.2%),
urine infections 3 patients (1.7%), and CNS or other
infections 3 patients (1.7%), including diagnoses made in
other departments (oncology, surgical). Multiple regres-
sion analyses showed various clinical factors to be inde-
pendently related to the range of antibiotic coverage in
PICU (Table 3). Especially patients who needed various
interventions during their hospitalisation, tended to
receive larger number of antibiotics.
Correlation to outcome
When restricted to the patients with free history, PICU-
related nosocomial infections were diagnosed in 13
Isolated microorganisms and antibiotics in PICU Figure 5
Isolated microorganisms and antibiotics in PICU. Dis-
tribution of groups of numbers of positive cultures with iso-
lated pathogenic microorganisms in PICU patients receiving 
or not antibiotics (percentage scale 100%).Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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patients (7.5%), with mortality rate 18% for the sepsis
group, but none for VAP group. When expanding to the
whole group (including cancer and chronic disease
patients with nosocomial infection developed before
admission to the PICU) nosocomial sepsis mortality
increased to 23% and differed significantly from the null
mortality associated with VAP (p < .03). Mortality rate
(30.8%) in the PICU-related sepsis group (13/8.3%) was
significantly higher compared to the 7.6% of the non-sep-
tic patients in PICU or the 11.8% of the admitted septic
patients (p < .02). All 13 patients of the PICU-related sep-
sis group who died were high-risk patients with cancer (6/
46.2%), chronic illnesses (5/38.5%), and end-stage organ
failure (2/15.4%).
The percent antibiotic coverage of patients did not differ
between survivors and non-survivors (81.5% vs. 70.6%)
although the total administered number of antibiotics
was different between the two groups. Higher percentage
of non-survivors was supported by mechanical ventilation
compared to survivors (97 ± 2.9% vs. 35 ± 3.1%, p <
.0001). In relation to the maximum daily number of anti-
biotics, however, there were no significant differences
between non-survivors and survivors, although they dif-
fered significantly regarding the PRISM (26.9 vs. 8.9, p <
.0001), the possibility of death by PRISM (48.5 vs. 7.7, p
< .0001), the TISS (44.7 vs. 22.4, p < .0001), and the age
(9,3  ναντι 4,6, p < .0001). Although the cumulative
number of administered antibiotics did not correlate with
mortality (9.8%), it was significantly related to the sever-
ity scoring systems PRISM (p < .001), TISS (p < .002) and
the probability of death by PRISM (p < .002).
Discussion
We demonstrated in this study that although a high per-
centage of critically ill children were receiving antibiotics
in PICU (79%), most of them had already been receiving
antibiotics before admission (68%). We also identified
potential risk factors for increasing use of antibiotics in an
intensive care setting. We further showed that the maxi-
mum and the cumulative per patient number of adminis-
tered antibiotics, which the patients were receiving in
PICU or at discharge, were significantly correlated with
the number of antibiotics that the patients were already
receiving on the admission day. Additionally, our study
demonstrated three important results as consequences of
following a strict approach to addressing the problem of
antibiotic use in PICU. The first is that the mean number
of antibiotics per patient in PICU was reduced compared
to the mean number of antibiotics received upon admis-
sion, especially among oncology and neurosurgery
patients. Use of monotherapy was more often in PICU
(46% vs. 33%) whereas use of three antibiotics was less
often (5.7% vs. 6.9%) than the day before admission. The
second is that the duration of antibiotic usage was short-
ened, since the antibiotic days in PICU represented only
62.3% of the cumulative length of stay days compared to
the 67.2% coverage at admission day. The third is that the
cumulative sum of received antibiotics during hospitaliza-
tion in PICU was significantly related to the number of
isolated microorganisms, whereas this correlation was
only borderline for the admission antibiotics.
A substantial proportion of PICU patients consists of
oncology patients or patients with chronic diseases or sep-
sis (48% in our unit, 32.8% presented with septic shock).
Other patients, presented with either severe community
infections (meningococcus-induced purpura fulminans)
or nosocomial infections from multi-resistant strains,
might eventually need initiation or modification of pre-
existed antibiotic regimens or initiation of combined anti-
biotic treatment with broad-spectrum antibiotics. In this
study the increased probability of covering severely ill
children with antibiotics was shown by the significant cor-
relation between the cumulative number of administered
antibiotics and the severity scoring systems PRISM, TISS
or the probability of death by PRISM. We further showed
that prior administration of antibiotics, presence of a
Table 3: Multiple regression analyses of the range of antibiotic coverage related to various independent clinical determinants
Dependent variable Independent determinant p value
Cumulative number of antibiotics Prior administration of antibiotics .0001
Presence of a bloodstream infection .0001
Positive bronchial cultures .0001
Negative outcome .0001
Severity of illness (PRISM) .03
Development of MOSF .002
Immunodeficiency .001
Number of central catheters .03
Maximum daily number of antibiotics Interventional TISS .007
Duration of antibiotic coverage Length of stay .0001Annals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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bloodstream infection, positive bronchial cultures,
mechanical ventilation, immunodeficiency, number of
central catheters, a negative outcome, a high PRISM or
interventional TISS, development of MOSF, and length of
stay were all independently related to increased possibility
of critically ill children receiving antibiotics in PICU. A
previous study also showed that a PRISM score greater
than 10 on PICU admission characterizes a population
within the PICU at increased risk of infection [21]. Other
researchers also showed that duration of MV and duration
of stay in the PICU increase the risk of developing noso-
comial infection [22], or that increasing severity of illness,
compromise of the immune system, invasive interven-
tions, and admission of patients from other health care
facilities increase antibiotic resistance and, accordingly,
antibiotic usage [23,24].
Several sources of inappropriate antibiotic utilization
were identified in various studies. In our study, failure to
discontinue treatment in the wards after starting empiric
therapy and prolonged or excessive prophylaxis were the
main reasons for inappropriate antibiotic utilization of
admitted patients. Especially more than 80% of the oncol-
ogy patients and more than 90% of the neurosurgical
patients, or patients suffering from chronic illnesses, or
priority III patients were covered with antibiotics for treat-
ment or prophylaxis of their illnesses. Almost half of
patients of these groups had been receiving prophylactic
or empiric antibiotic regimens with 2 or more antibiotics.
Another significant proportion of admitted patients had
also been receiving antibiotics for non-proven suspected-
infection or as a prophylaxis for community infection,
despite the fact that many infectious disease societies pub-
lished clinical guidelines to control administration of
antibiotics [25] and to ensure optimal therapy while min-
imizing drug costs [26]. Such over-prescription might
relate to misinformation on the part of physicians,
pharmacists, and patients. Diagnostic uncertainty might
also contribute to physicians prescribing the drugs for pri-
marily viral infections to cover the "chance" of bacterial
infection. Community wide consumption of antibiotics,
however, has been strongly associated with infection or
colonization with resistant organisms [27]. Similarly,
prior antimicrobial therapy has been recognized as an
important risk factor for the administration of inadequate
antimicrobial treatment among ICU patients with clini-
cally suspected infections [10]. These reports are in
accordance with our findings, which showed that more
isolates, nosocomial infections and cumulative
antibiotics were prescribed in the group covered with anti-
biotics before admission to the PICU. Fortunately, most
of our patients with head injuries were admitted to the
PICU directly and did not receive prophylactic antibiotic
therapy. This policy has been verified by a recent study
which showed that the prophylactic administration of
more than 1 antibiotic for more than 24 hours following
severe trauma did not offer additional protection against
sepsis, organ failure, and death, but increased the proba-
bility of antibiotic-resistant infections [28]. Resistance has
been shown to be proportional to the volume of antimi-
crobial consumption, and reduction in resistance may
require a similar reduction in the consumption [29]. Sim-
ilarly, recent work has shown that isolates obtained from
patients in the hematology ward were more often resistant
to antimicrobial agents than isolates obtained from
patients in the intensive care unit, and the agents against
which the highest rates of resistance were found were also
used more frequently in the hematology ward than in the
intensive care unit [30]. Therefore, hospitals, and not only
intensive care units, are common sites for breeding resist-
ant bacteria, which require more expensive antibiotics,
lead to prolonged hospitalization, and increase morbid-
ity, mortality, and the cost of care [31,32]. In our study,
nosocomial infections doubled the mortality of PICU
patients and increased significantly the length of stay, the
antibiotic usage and, presumably, their accompanying
cost.
Several groups of clinical investigators have demonstrated
a strong association between prior antibiotic administra-
tion and the emergence of VAP (as well as other
nosocomial infections) caused by antibiotic-resistant bac-
teria [33,34]. Interestingly, infection with antibiotic-
resistant bacteria has been associated with an increased
risk of hospital mortality [35-38]. It was suggested there-
fore that scheduled changes of antibiotic classes for the
empirical treatment of gram-negative bacterial infections
could reduce the occurrence of inadequate antibiotic
treatment for nosocomial infections and improve, there-
fore, the outcomes of critically ill patients [39]. This is fur-
ther supported from our results that: a) mortality of the
community and hospital-related sepsis (11.8%) did not
differ compared to the non-sepsis PICU-mortality (7.6%);
b) the PICU-related sepsis mortality was restricted to the
high-risk patients with cancer or chronic illnesses; c) all
the VAP patients survived.
There is reason to believe that the epidemiology of antibi-
otic usage in PICU settings may be different from that in
other hospital settings because the patients' preadmission
health status, the compromise of their immune systems,
and their outpatient exposure to antibiotics are different
from those seen in adults [40,41]. Despite all these diffi-
culties, by following a strict protocol including surveil-
lance cultures, we managed to have many antibiotics
readily available for use in our unit (data not shown),
according to culture results. Accordingly, not only the
mean number of antibiotics per patient in PICU was
reduced among oncology and neurosurgery patients, but
also at discharge one fourth of our patients did not receiveAnnals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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any antibiotic. This is in accordance to a recent report sug-
gesting that among febrile patients in PICU, applying
common-use standards could have reduced approxi-
mately 15% of total antibiotic-days [42]. We believe that
an even higher reduction of antibiotic prescription in our
PICU could have been feasible, if we had attempted to
restrict previously prescribed broad-spectrum empiric
antibiotic regimens more rigorously or discontinue them,
when appropriate.
The high rates of antibiotic misuse in specific departments
of hospitals highlight the need for a thorough revision of
strategies that deal with the proper use of antibiotics. The
so-called 'optimal use of all antibiotics', restriction guide-
lines and use of a combination of antibiotics are well-
established strategies but ignored in most non-PICU
departments [43]. In a recent study surveillance cultures
allowed that two thirds of the resistant isolates were
imported and that the introduction of newer potent sys-
temic antibiotic combinations failed to control the
endemic reservoir of these multidrug-resistant bacteria
[44]. We now showed that not only increasing rates of
resistant isolates but also increasing numbers of wide-
range antibiotics are also imported into PICU. Interest-
ingly, we showed that patients already receiving antibiot-
ics were at higher risk of been infected with nosocomial
microorganisms, mainly isolated in blood and bronchial
cultures, and of developing various nosocomial infec-
tions. Accordingly, these patients needed significantly
more changes of antibiotic regimens during their hospi-
talization in PICU and received significantly higher daily
and cumulative number of broad-spectrum antibiotics
and agents against fungi. Supporting this view is the
observation that most patients colonized or infected with
ceftazidime – resistant gram-negative bacilli had positive
surveillance cultures at the time of admission to the inten-
sive care, suggesting that acquisition frequently occurred
in other wards and institutions [8]. Although we restricted
the use broad-spectrum cephalosporins as empirical treat-
ment of nosocomial infections in our unit, a high percent-
age of admitted post surgical patients had been already
exposed to cephalosporins, which they were still receiving
upon admission.
These observations require that strategies to control infec-
tions in PICUs be reassessed and expanded to the wards.
Published guidelines are available from several societies
for providing optimal therapy and curtailing resistance in
hospitals [25]. However, they are based primarily on
expert opinion and what is needed is point-of-care deliv-
ery of clinical guidelines and evidence-based recommen-
dations [45]. It has been shown that peer education
improves quality of care and reduces cost of antibiotic pre-
scribing in office practices [46]. The use of computerized
antiinfectives-management programs might lead to signif-
icant reductions in excess drug dosages and antibiotic-sus-
ceptibility mismatches, in the mean number of days of
excessive drug dosage and in the cost of antiinfective
agents [47]. Furthermore, new potential strategies, such as
combination of dosage optimization and antibiotic
cycling, require further study and evaluation. We propose
that additional long-term studies are required to better
track the impact of liberal use of antibiotics in wards and
to determine the optimal modalities of programmed
changes of antibiotic prescribing as an antibiotic
resistance prevention or control strategy of prolonged
prophylaxis or empiric antibiotic misuse. Such modalities
should also include institution of an effective infection
control committee and a strict hospital antibiotic policy
creating barriers to inappropriate practices and limiting
prescribers' autonomy.
Several limitations of this study should be noted. First, it
was conducted at a single unit. Therefore, these results
may not be applicable to other PICUs with lower or
higher rates of patients with cancer or chronic diseases.
Second, we examined a mixed group of medical and sur-
gical patients requiring intensive care. It is possible that
other types of critically ill patients (neonates, cardiotho-
racic patients) may have different rates of pre-admission
antimicrobial treatment and different risk factors
predisposing to increasing administration of antibiotics.
Finally, the observational nature of this investigation does
not allow us to draw an absolute causal relationship
between the administration of antimicrobial treatment
and specific risk factors. Simultaneously, these limitations
themselves constitute a unique advantage of this study,
the results of which could be fully explored, based on
homogeneous data and strategies. It is for this reason that
the range of antibiotic coverage before and after PICU
admission could be clearly shown and compared. Further-
more, predisposing factors influencing the use of
antibiotics in critically ill children could be probably bet-
ter established in an homogenous intensive care setting
population than in multicenter studies with various poli-
cies, multiple interventions, different methods and mixed
populations.
Conclusions
Prior antimicrobial therapy should be recognized as an
important risk factor for extended antimicrobial therapy
among critically ill children. The significant proportion of
immuno-compromised or cancer patients, patients with
prolonged length of stay, the increased degree of interven-
tions and development of nosocomial infections restrict
clinical efforts aimed at reducing antimicrobial treatment
in critically ill patients. Despite these limitations, how-
ever, the antibiotic usage before and at PICU admission
for prophylaxis and suspected infections might be
reduced at about entry levels (community, nosocomialAnnals of Clinical Microbiology and Antimicrobials 2004, 3 http://www.ann-clinmicrob.com/content/3/1/4
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infections) by imposing definite clinical indications,
guided by microbial studies. Although such strategies
might well be implemented and tightly controlled in
closed health care systems such as intensive care units, the
challenge now is to maintain their efficacy in a less restric-
tive system and for a wider array of prescribers.
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